In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark's health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child's risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These positive findings in other studies persisted even after efforts to reduce confounding by indication through adjustment for maternal psychiatric condition (29, 31, 43, 44), restriction to mothers with psychiatric conditions (27–30, 32), and propensity weighting methods (30).”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [28]
In the citing paper
“For ASD as the outcome, seven case–control studies (involving 291,468 patients and 13,243 cases of ASD) [17, 18, 26–29, 32] and eight cohort studies (involving 3,294,218 patients and 27,342 cases of ASD) [16, 19, 25, 30, 31, 33–35] were included.”
In the citing paper
“there was a total of 15 observational studies measuring ASD as an outcome [16–19, 25–35].”
In the citing paper
“Three studies used the same data source and related patients from Denmark [28, 30, 33] and three from Sweden [32, 34, 35].”
Citations
Cites
(1943) · The Nervous child · Cited by 8,870
Autistic disturbances of affective contact.
Kanner, L. (1968) · PubMed · Cited by 3,140
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583 · cited 1×
“Negative controls are used to indicate that potential confounding may exist, if a result with a non-causal explanation is observed (Lipsitch et al. 2010).”
BackgroundCohort study of depressed mood during pregnancy and after childbirth
Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001) · BMJ · doi:10.1136/bmj.323.7307.257 · Cited by 1,280 · cited 6×
“…of under-ascertainment of maternal depression because published estimates of the prevalence of maternal depression during pregnancy in Europe range from 3 to 17 % (Evans et al. 2001; Josefsson et al. 2001; Lund et al. 2009; Olsen et al. 2004)—much higher than our observed prevalence of 0.6 %.”
BackgroundMethodResultInfluentialMaternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Atladóttir, H. Ó., Thorsen, P., Østergaard, L., Schendel, D. E., Lemcke, S., Abdallah, M., & Parner, E. T. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1006-y · Cited by 916
Assessing the sensitivity of regression results to unmeasured confounders in observational studies
Lin, D. Y., Psaty, B. M., & Kronmal, R. A. (1998) · Biometrics · doi:10.2307/2533848 · Cited by 742 · cited 1×
“Following the method of Lin et al. (1998) we assumed a binary confounder U existed such that U increased the risk of ASD, and that U was more prevalent in SSRI-exposed mothers than in unexposed mothers.”
MethodRisk Factors for Autism: Perinatal Factors, Parental Psychiatric History, and Socioeconomic Status
Larsson, H. J., Eaton, W. W., Madsen, K. M., Vestergaard, M., Olesen, A. V., Agerbo, E., Schendel, D., Thorsen, P., & Mortensen, P. B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi123 · Cited by 727
Sibling Comparison Designs: Bias From Non-Shared Confounders and Measurement Error
Frisell, T., Öberg, S., Kuja-Halkola, R., & Sjölander, A. (2012) · Epidemiology · doi:10.1097/ede.0b013e31825fa230 · Cited by 551
CARTER, A. S., GARRITY-ROKOUS, F. E., CHAZAN-COHEN, R., LITTLE, C., & BRIGGS-GOWAN, M. J. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200101000-00012 · Cited by 537 · cited 1×
“Associations between maternal depression, the chief indicating condition for SSRI use, and developmental psychopathology in children have been reported (Brennan et al. 2000; Caplan et al. 1989; Carter et al. 2001; Deave et al. 2008; Huot et al. 2004).”
BackgroundBrennan, P. A., Hammen, C. L., Andersen, M. J., Bor, W., Najman, J. M., & Williams, G. M. (2000) · Developmental Psychology · doi:10.1037//0012-1649.36.6.759 · Cited by 519
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Croen, L. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.73 · Cited by 510 · cited 4×
“…California reported an autism spectrum disorders (ASD) odds ratio (OR) adjusted for age, race/ethnicity, and education of mother, birth weight, sex, and birth year of child, and birth facility associated with any prenatal SSRI use of 2.2 (95 % confidence interval (CI) 1.4, 2.3) (Croen et al. 2011).”
BackgroundInfluentialDurkin, M. S., Maenner, M. J., Meaney, F. J., Levy, S. E., DiGuiseppi, C., Nicholas, J. S., Kirby, R. S., Pinto-Martin, J. A., & Schieve, L. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011551 · Cited by 509
Serotonin and brain development: role in human developmental diseases
Whitaker-Azmitia, P. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00615-3 · Cited by 506 · cited 2×
“2007), and there are several biologically plausible explanations for our findings involve serotoninergic pathways during development (Anderson et al. 2004; Cook et al. 1988; Lam et al. 2006; Whitaker-Azmitia 2001).”
BackgroundThe impact of maternal depression in pregnancy on early child development
Deave, T., Heron, J., Evans, J., & Emond, A. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01752.x · Cited by 479
Prevalence of depressive symptoms in late pregnancy and postpartum
Josefsson, A., Berg, G., Nordin, C., & Sydsjö, G. (2001) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2001.080003251.x · Cited by 466 · cited 6×
“…of under-ascertainment of maternal depression because published estimates of the prevalence of maternal depression during pregnancy in Europe range from 3 to 17 % (Evans et al. 2001; Josefsson et al. 2001; Lund et al. 2009; Olsen et al. 2004)—much higher than our observed prevalence of 0.6 %.”
BackgroundMethodResultInfluentialIncreasing use of antidepressants in pregnancy
Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.033 · Cited by 458
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
Atladóttir, H. O., Pedersen, M. G., Thorsen, P., Mortensen, P. B., Deleuran, B., Eaton, W. W., & Parner, E. T. (2009) · Pediatrics · doi:10.1542/peds.2008-2445 · Cited by 404
Use of antidepressant medications during pregnancy: a multisite study
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.036 · Cited by 403
Sex differences in the evaluation and diagnosis of autism spectrum disorders among children
Giarelli, E., Wiggins, L. D., Rice, C. E., Levy, S. E., Kirby, R. S., Pinto-Martin, J., & Mandell, D. (2010) · Disability and Health Journal · doi:10.1016/j.dhjo.2009.07.001 · Cited by 398
Autism, affective and other psychiatric disorders: Patterns of familial aggregation
BOLTON, P. F., PICKLES, A., MURPHY, M., & RUTTER, M. (1998) · Psychological Medicine · doi:10.1017/s0033291797006004 · Cited by 387 · cited 2×
“…disorders before the birth of the child are more common among parents of children with ASD than parents of children without a diagnosis of ASD, and maternal depression appears to be a greater risk factor than paternal depression (Bolton et al. 1998; Daniels et al. 2008; Rai et al. 2013).”
BackgroundRai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013) · BMJ · doi:10.1136/bmj.f2059 · Cited by 365 · cited 5×
“Based on the assumption that the associations are causal, this calculation suggests that between 0.6 and 1.7 % of the ASD cases in the population could be prevented if prenatal SSRI exposure was eliminated; an estimate quite similar to that of Rai et al. (2013).”
BackgroundResultInfluentialSelf-citationNeurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318 · cited 2×
“2007), and there are several biologically plausible explanations for our findings involve serotoninergic pathways during development (Anderson et al. 2004; Cook et al. 1988; Lam et al. 2006; Whitaker-Azmitia 2001).”
BackgroundWhole blood serotonin in autistic and normal subjects
Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1987.tb00677.x · Cited by 313
Bonnin, A., & Levitt, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.005 · Cited by 311 · cited 1×
“From a mechanistic perspective, however, these epidemiologic data add evidence to basic neurobiologic research (Bonnin and Levitt 2011) suggesting that maternal prenatal serotonin metabolism may be part of a causal pathway to ASD worth further study.”
BackgroundNeonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry
Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C. S., & Paul, I. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300823 · Cited by 302
Gislason, G. H., Rasmussen, J. N., Abildstrøm, S. Z., Gadsbøll, N., Buch, P., Friberg, J., Rasmussen, S., Køber, L., Stender, S., Madsen, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi705 · Cited by 301
Parental psychiatric disorders associated with autism spectrum disorders in the offspring
Daniels, J. L., Forssen, U., Hultman, C. M., Cnattingius, S., Savitz, D. A., Feychting, M., & Sparen, P. (2008) · Pediatrics · doi:10.1542/peds.2007-2296 · Cited by 288
A heuristic approach to the formulas for population attributable fraction
Hanley, J. A. (2001) · Journal of Epidemiology and Community Health · doi:10.1136/jech.55.7.508 · Cited by 280 · cited 2×
“We estimated the population attributable fraction (Hanley 2001) based on observed adjusted OR of 1.9 for any prenatal SSRI exposure and the observed exposure prevalence (0.7”
BackgroundMethodInfluentialKieler, H., Artama, M., Engeland, A., Ericsson, O., Furu, K., Gissler, M., Nielsen, R. B., Norgaard, M., Stephansson, O., Valdimarsdottir, U., et al. (2011) · BMJ · doi:10.1136/bmj.d8012 · Cited by 277
Prevalence of major depression and stress indicators in the Danish general population
Olsen, L. R., Mortensen, E. L., & Bech, P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.0001-690x.2003.00231.x · Cited by 259 · cited 4×
“…of under-ascertainment of maternal depression because published estimates of the prevalence of maternal depression during pregnancy in Europe range from 3 to 17 % (Evans et al. 2001; Josefsson et al. 2001; Lund et al. 2009; Olsen et al. 2004)—much higher than our observed prevalence of 0.6 %.”
BackgroundMethodInfluentialSelf-citationTHE AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
(1921) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1921.tb30898.x · Cited by 259
Lauritsen, M. B., Jørgensen, M., Madsen, K. M., Lemcke, S., Toft, S., Grove, J., Schendel, D. E., & Thorsen, P. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0818-0 · Cited by 239
Schendel, D., & Bhasin, T. K. (2008) · Pediatrics · doi:10.1542/peds.2007-1049 · Cited by 230 · cited 2×
“We restricted gestational age in our sample because extremely preterm or post-term birth have previously been associated with autism risk (Schendel and Bhasin 2008).”
MethodWeikum, W. M., Oberlander, T. F., Hensch, T. K., & Werker, J. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121263109 · Cited by 202 · cited 2×
“In addition, recent studies have suggested a possible link between prenatal antidepressant exposure and neurodevelopmental outcomes including altered speech perception (Weikum et al. 2012)”
BackgroundDiabetes and the Risk of Developing Parkinson’s Disease in Denmark
Schernhammer, E., Hansen, J., Rugbjerg, K., Wermuth, L., & Ritz, B. (2011) · Diabetes Care · doi:10.2337/dc10-1333 · Cited by 198 · cited 2×
“2013) and these coding schemes have been employed in a variety of studies (Gislason et al. 2006; Kaae et al. 2010; Moth et al. 2008; Schernhammer et al. 2011).”
BackgroundMethodUse of selective serotonin reuptake inhibitors during pregnancy and risk of autism
Hviid, A., Melbye, M., & Pasternak, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301449 · Cited by 195 · cited 2×
“…ratio of 1.20 (95 % CI 0.90–1.61) adjusted for year of birth, maternal parity, maternal age, country of origin, maternal place of residence, maternal smoking status, maternal employment status, other drug use before delivery and maternal psychiatric diagnoses before delivery (Hviid et al. 2013).”
BackgroundInfluentialThe impact of gestational stress and prenatal growth on emotional problems in offspring: a review
Rice, F., Jones, I., & Thapar, A. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00895.x · Cited by 163 · cited 1×
“Maternal hypothalamo–pituitary–adrenal (HPA) activity in response to psychological stress, which can be caused by depression, has been linked to adverse neurodevelopmental effects (Rice et al. 2007).”
BackgroundAntidepressant exposure in pregnancy and risk of autism spectrum disorders
Sorensen, M. J., Christensen, J., Parner, E. T., Grønborg, T. K., Vestergaard, M., Schendel, D., & Pedersen, L. H. (2013) · Clinical Epidemiology · doi:10.2147/clep.s53009 · Cited by 163
Maternal depression and the emotional development of the child
Caplan, H. L., Cogill, S. R., Alexandra, H., Robson, K. M., Katz, R., & Kumar, R. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.6.818 · Cited by 160 · cited 1×
“Associations between maternal depression, the chief indicating condition for SSRI use, and developmental psychopathology in children have been reported (Brennan et al. 2000; Caplan et al. 1989; Carter et al. 2001; Deave et al. 2008; Huot et al. 2004).”
BackgroundBurstyn, I., Sithole, F., & Zwaigenbaum, L. (2010) · Chronic Diseases and Injuries in Canada · doi:10.24095/hpcdp.30.4.04 · Cited by 159 · cited 2×
“Variables reflecting parental age, parental psychiatric history, gestational age, birth weight, parental history of autoimmune disease, and number of live births, obstetric complications, and family socioeconomic status (a combination of parental income and highest level of education) were available in the Danish regi…”
MethodSelf-citationBakker, M. K., Kölling, P., Van Den Berg, P. B., De Walle, H. E. K., & De Jong van den Berg, L. T. W. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03048.x · Cited by 158 · cited 4×
“(Bakker et al. 2008; Kieler et al. 2012).”
BackgroundResultInfluentialTextbook of Pharmacoepidemiology
Strom, B. L., Kimmel, S. E., & Hennessy, S. (2013) · Wiley eBooks · doi:10.1002/9781118344828 · Cited by 153
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Lund, N., Pedersen, L. H., & Henriksen, T. B. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.164 · Cited by 153 · cited 7×
“…of under-ascertainment of maternal depression because published estimates of the prevalence of maternal depression during pregnancy in Europe range from 3 to 17 % (Evans et al. 2001; Josefsson et al. 2001; Lund et al. 2009; Olsen et al. 2004)—much higher than our observed prevalence of 0.6 %.”
BackgroundMethodResultInfluentialHanley, G. E., Brain, U. M., & Oberlander, T. F. (2013) · Early Human Development · doi:10.1016/j.earlhumdev.2012.12.012 · Cited by 146 · cited 2×
“and motor, social–emotional and adaptive behavior (Hanley et al. 2013).”
BackgroundJimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Jensen, J. K., Afzal, S., Gislason, G. H., Torp-Pedersen, C., & Poulsen, H. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001148 · Cited by 139 · cited 2×
“The published literature indicates a higher rate of maternal depression in other Nordic countries compared to what is found in the registers (Evans et al. 2001; Jimenez-Solem 2012; Josefsson et al. 2001; Kieler et al. 2012; Lund et al. 2009; Olesen et al. 2001), suggesting that depression prevalence as measured in our…”
ResultHeterogeneity and Homogeneity Across the Autism Spectrum: The Role of Development
Jones, W., & Klin, A. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819f6c0d · Cited by 128 · cited 1×
“Also prenatal stress and certain serotonin transporter genotypes may have the combined effect of producing changes in social interaction and social interest in the offspring consistent with those observed in individuals with ASD (Jones and Klin 2009).”
ResultA Developmental Neurotoxicity Evaluation of the Effects of Prenatal Exposure to Fluoxetine in Rats
Vorhees, C. V. (1994) · Fundamental and Applied Toxicology · doi:10.1006/faat.1994.1098 · Cited by 123 · cited 2×
“ciated with prenatal SSRI exposure (Vorhees et al. 1994) (Maciag et al.”
BackgroundHUOT, R. L., BRENNAN, P. A., STOWE, Z. N., PLOTSKY, P. M., & WALKER, E. F. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.028 · Cited by 120 · cited 1×
“Associations between maternal depression, the chief indicating condition for SSRI use, and developmental psychopathology in children have been reported (Brennan et al. 2000; Caplan et al. 1989; Carter et al. 2001; Deave et al. 2008; Huot et al. 2004).”
BackgroundBakker, M. K., Kerstjens‐Frederikse, W. S., Buys, C. H. C. M., de Walle, H. E. K., & de Jong‐van den Berg, L. T. W. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20641 · Cited by 117 · cited 1×
“There is accumulating evidence that mothers treated with SSRIs during pregnancy may experience increased rates of adverse reproductive outcomes (Bakker et al. 2010; Lund et al. 2009).”
BackgroundPhotosensitizing Medication Use and Risk of Skin Cancer
Kaae, J., Boyd, H. A., Hansen, A. V., Wulf, H. C., Wohlfahrt, J., & Melbye, M. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0652 · Cited by 100 · cited 2×
“2013) and these coding schemes have been employed in a variety of studies (Gislason et al. 2006; Kaae et al. 2010; Moth et al. 2008; Schernhammer et al. 2011).”
BackgroundMethodDuration of antidepressant use during pregnancy and risk of major congenital malformations
Ramos, É., St-André, M., Rey, É., Oraichi, D., & Bérard, A. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042523 · Cited by 89 · cited 2×
“…among the most commonly used medications in pregnancy, with prescription frequency estimates in pregnant women ranging from 0.7 to 1.4 % in Nordic countries (JimenezSolem et al. 2013; Kieler et al. 2012) and 5–13 % in the United States (Andrade et al. 2008; Cooper et al. 2007; Ramos et al. 2008).”
BackgroundInfluentialBodnar, L. M., Siega‐Riz, A. M., Simhan, H. N., Diesel, J. C., & Abrams, B. (2010) · Obesity · doi:10.1038/oby.2010.25 · Cited by 89 · cited 1×
“Sensitivity Analyses We used a Monte Carlo simulation approach similar to the methods used by Bodnar et al. (2010) to explore the potential impact of under-reporting of SSRI use and depression in the register.”
MethodInvited Commentary: The Use of Sibship Studies to Detect Familial Confounding
Susser, E., Eide, M. G., & Begg, M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq196 · Cited by 85 · cited 1×
“Sibling analyses, similar to twin studies, can partially account for confounding from familial genetic or environmental sources, such as maternal depression (Susser et al. 2010).”
BackgroundFree serotonin in plasma: Autistic children and their first-degree relatives
Cook, E. H., LEVENTHAL, B. L., & Freedman, D. X. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90192-8 · Cited by 84 · cited 3×
“…metabolism are one of the few consistent biological observations associated with ASD (Anderson et al. 1987) and several lines of evidence suggest that alterations in the serotonergic neurotransmitter system might be a mechanistic pathway leading to ASD (Anderson et al. 1987; Cook et al. 1988).”
BackgroundOlesen, C., Thrane, N., Nielsen, G. L., Sørensen, H. T., & Olsen, J. (2001) · Respiration · doi:10.1159/000050507 · Cited by 74 · cited 1×
“…compared to what is found in the registers (Evans et al. 2001; Jimenez-Solem 2012; Josefsson et al. 2001; Kieler et al. 2012; Lund et al. 2009; Olesen et al. 2001), suggesting that depression prevalence as measured in our study (and in the other published studies using Danish register data)…”
ResultDevelopmental effects of SSRIs: lessons learned from animal studies
Borue, X., Chen, J., & Condron, B. G. (2007) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.06.003 · Cited by 62 · cited 2×
“Selective serotonin reuptake inhibitors are known to cross the placenta (Borue et al. 2007), and there are several biologically plausible explanations for our findings involve serotoninergic pathways during development (Anderson et al. 2004; Cook et al. 1988; Lam et al. 2006; Whitaker-Azmitia 2001).”
BackgroundSSRI Use During Pregnancy and Risk of Stillbirth and Neonatal Mortality
Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Lander, A. R., Afzal, S., Torp-Pedersen, C., & Poulsen, H. E. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081251 · Cited by 60
Anderson, G. M., Czarkowski, K. A., Ravski, N., & Epperson, C. N. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000136278.23672.a0 · Cited by 57 · cited 2×
“2007), and there are several biologically plausible explanations for our findings involve serotoninergic pathways during development (Anderson et al. 2004; Cook et al. 1988; Lam et al. 2006; Whitaker-Azmitia 2001).”
BackgroundPriorities for autism spectrum disorder risk communication and ethics
Yudell, M., Tabor, H. K., Dawson, G., Rossi, J. P., Newschaffer, C. J., & Working Group in Autism Risk Communication and Ethics (2012) · Autism · doi:10.1177/1362361312453511 · Cited by 38
Self-citationMoth, G., Schiøtz, P. O., & Vedsted, P. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-130 · Cited by 21
Special Applications of Pharmacoepidemiology
chapter:, T. F. I. C. T. W. S. O. T., Lee, D. J., Majumdar, S. R., Lipton, H. L., Soumerai, S. B., Vellozzi, C. J., Chen, R. T., Glanz, J. M., Marinac‐Dabic, D., Normand, S. T., et al. (2013) · Wiley eBooks · doi:10.1002/9781118344828.ch22 · Cited by 8
Special Applications of Pharmacoepidemiology
Lee, D. M., Majumdar, S. R., Lipton, H. L., Soumerai, S. B., Hennessy, S., Davis, R. L., Chen, R. T., Bright, R. A., Mitchell, A. A., Graham, D. J., et al. (2006) · Wiley eBooks · doi:10.1002/9781118707999.ch27 · Cited by 7
Bonnin, A., Levitt, P. R., & Conte, S. (2011) · Cited by 2
Cited by
Autism Spectrum Disorder: Classification, diagnosis and therapy
Sharma, S. R., Gonda, X., & Tarazi, F. I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.007 · Cited by 673
Brummelte, S., Mc Glanaghy, E., Bonnin, A., & Oberlander, T. F. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.037 · Cited by 306
“…in utero SSRI exposure to an increased risk for complex disorder development such as autism spectrum disorders (Boukhris, Sheehy, Mottron, & Berard, 2016; Gentile, 2015) (Clements et al., 2015; Croen et al., 2011; Gidaya et al., 2014; Man et al., 2015; Rai et al., 2013; Sorensen et al., 2013).”
Antidepressant use during pregnancy and the risk of autism spectrum disorder in children
Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.3356 · Cited by 297
“Maternal age also increased the risk of ASD, as was observed in other studies.(22,24) Severalmechanismsmayaccount for the increased risk of ASD associated with maternal use of ADs during pregnancy.”
ResultEnvironmental factors influencing the risk of autism
Karimi, P., Kamali, E., Mousavi, S. M., & Karahmadi, M. (2017) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.200272 · Cited by 243
Mandy, W., & Lai, M. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12501 · Cited by 283
“…of children without ASC in terms of maternal use of SSRI during pregnancy, either indexed by prescription records (Croen, Grether, Yoshida, Odouli, & Hendrick, 2011; Rai et al., 2013) or maternal retrospective report (Gidaya et al., 2014; Harrington, Lee, Crum, Zimmerman, & Hertz-Picciotto, 2014).”
Background
Metadata
- Authors
- Gidaya, N. B., Lee, B. K., Burstyn, I., Yudell, M., Mortensen, E. L., & Newschaffer, C. J.
- Affiliations
- Drexel University (US)
- University of Copenhagen (DK)
- Corresponding author
- Gidaya, Nicole B.
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 2014-05-07
- Volume
- 44
- Issue
- 10
- Pages
- 2558-2567
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W2061787422
- Cited by
- 115
- References
- 64
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 8 · 2022: 2 · 2021: 6 · 2020: 10 · 2019: 18 · 2018: 12 · 2017: 24 · 2016: 15 · 2015: 10 · 2014: 2
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Autism and Developmental Disorders (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Drexel University
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- autism spectrum disorder, selective serotonin reuptake inhibitors, prenatal drug exposure, maternal medication use, pregnancy, ASD risk factors, duration of exposure
- MeSH terms
- Adult, Child, Child Development Disorders, Pervasive, Denmark, Depression, Female, Humans, Male, Middle Aged, Pregnancy, Prenatal Exposure Delayed Effects, Registries, Risk Factors, Case-Control Studies, Selective Serotonin Reuptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.